An Open-label Phase 1 Trial to Determine the Pharmacokinetics, Pharmacodynamics, and Safety of GH001 Administered Via a Proprietary Aerosol Delivery Device in Healthy Subjects
Phase: PHASE1 | Sponsor: GH Research Ireland Limited | Compound: Psychedelic
- Status
- recruiting
- Institution
- GH Research Ireland Limited
- Start date
- 2024-08-01
- End date
- 2025-02-01
- Registry ID
- NCT06511947
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.